All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news

RSS

← First12345...807Next →

hiv & aids news selected from other sources

  • Hepatitis C treatment
    From chronic to cured: could Australia be the first country in the world to eliminate hep C?
    Kirby Institute | 17 hours ago

    Australia is on track to eliminate hepatitis C by 2026, a new report released by the Kirby Institute on World Hepatitis Day shows.

  • PrEP
    Philippines trials anti-HIV drug as cases hit record high
    Thomson Reuters | 27 July 2017

    The Philippines has kicked off a pilot project offering anti-HIV drugs to gays and transgender women as new infection rates in the country buck global trends and hit a record high.

  • Achieving the 90-90-90 target
    HIV treatment: Strategies to reach the next 10 million patients
    Devex | 27 July 2017

    Campaigners know that reaching the next 10 million people with treatment will be harder in some ways. These patients are among the most difficult to reach: People living in conflict areas, stigmatized and criminalized populations — like men who have sex with men and sex workers — and young people, leery at the thought of taking HIV medication every day for the rest of their lives.

  • Side-effects
    New Data Shows Dramatic Reduction in Chronic Diarrhea Episodes with Crofelemer (Mytesi) Treatment
    Napo Pharmaceuticals press release | 27 July 2017

    Napo Pharmaceuticals, Inc., and Jaguar Animal Health, Inc. (Jaguar), announced today the results of a supplemental analysis of the long-term trial of crofelemer (Mytesi®) in patients with chronic HIV-related diarrhea. The analysis revealed a mean decrease of over 70 percent in diarrhea episodes versus baseline and over 50 percent of patients with complete resolution of their diarrhea.

  • Microbicides
    Dapivirine vaginal ring safe, acceptable for HIV prevention in teens
    Healio | 27 July 2017

    A monthly vaginal ring containing the antiretroviral dapivirine has demonstrated efficacy in girls younger than 18 years, according to phase 2a study results presented at the IAS Conference on HIV Science.

  • HIV testing
    IAS 2017: UNITAID, partners boost HIV self-test access in six African countries
    Science Speaks | 27 July 2017

    The UNITAID-led HIV Self-Testing Africa consortium will expand the reach of its project from Malawi, Zambia and Zimbabswe to include South Africa Lesotho and Swaziland leaders of the effort announced here Monday.

  • Prevention of mother-to-child transmission
    Vertical HIV transmission may be influenced by complex synergies with other STI – such as Cytomegalovirus
    BMJ Group blogs | 27 July 2017

    The apparently greater susceptibility of sub-Saharan African women to HIV infection has led researchers to consider the various potential synergies between HIV and other genital infections or conditions of the vaginal microbiome. A recent study brings this wider perspective to bear on mother-to-child transmission, casting some fresh light on the complex interrelation between the ‘vertical’ transmission of HIV and active and Cytomegalovirus (CMV) viruria.

  • Hepatitis and HIV
    ECDC estimate: Around 9 million Europeans are affected by chronic hepatitis B or C
    Eurekalert Inf Dis | 27 July 2017

    An estimated 4.7 million Europeans are living with chronic hepatitis B and almost 4 million with chronic hepatitis C infection. But large numbers of them are not aware of their infection as they have not yet been diagnosed. On of World Hepatitis Day, ECDC Director Andrea Ammon highlights the need for Europe to scale-up coverage of testing, prevention interventions and linkage to suitable treatment services to achieve the target of eliminating viral hepatitis by 2030.

  • Microbicides
    Rectal products for PrEP: Are they an option?
    BETA blog | 27 July 2017

    At the IAS 2017 conference this week, Ian McGowan, MD, PhD, FRCP, from University of Pittsburgh, discussed the need for (and challenges associated with) topical HIV prevention products, and a separate team of researchers presented promising findings from a very early study of a rectal HIV-prevention douche.

  • The search for a cure
    What can science learn from a child who has controlled HIV without drugs for more than 8 years?
    Science | 27 July 2017

    An HIV-infected child in South Africa who is controlling the virus without antiretroviral (ARV) drugs has reinvigorated the push to find ways to allow people to control the virus for prolonged periods without treatment.

← First12345...1338Next →

Conference news

News from the 9th IAS Conference on HIV Science (IAS 2017).

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Achieving the 90-90-90 target

With advances in HIV testing, treatment and care, some countries are making great progress towards the UNAIDS 90-90-90 target.

New EUROBulletin

Read the July edition of the Sexual Health & HIV Policy EUROBulletin.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.